Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Mucosal Melanoma”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT02071940
What this trial is testing

PLX3397 KIT in Acral aNd mucOsal Melanoma

Who this might be right for
Malignant Melanoma
The Christie NHS Foundation Trust 7
Testing effectiveness (Phase 2)Ended earlyNCT01864538
What this trial is testing

Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
ImmunoGenesis 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236528
What this trial is testing

Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT06961357
What this trial is testing

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 36
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Testing effectiveness (Phase 2)UnknownNCT04979585
What this trial is testing

Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma

Who this might be right for
Melanoma
Di Wu 66
Testing effectiveness (Phase 2)UnknownNCT04472806
What this trial is testing

Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
Fudan University 31
Not applicableLooking for participantsNCT07215988
What this trial is testing

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Who this might be right for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center 70
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT02023710
What this trial is testing

Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 182
Testing effectiveness (Phase 2)UnknownNCT03941795
What this trial is testing

Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma

Who this might be right for
Advanced Mucosal Melanoma
Peking University Cancer Hospital & Institute 99
Testing effectiveness (Phase 2)UnknownNCT06041724
What this trial is testing

Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma

Who this might be right for
Advanced Mucosal Melanoma
Fudan University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Large-scale testing (Phase 3)Study completedNCT00110019
What this trial is testing

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Mucosal MelanomaRecurrent MelanomaStage IIIA Skin Melanoma+3 more
National Cancer Institute (NCI) 823
Testing effectiveness (Phase 2)Study completedNCT01827111
What this trial is testing

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Ended earlyNCT04830124
What this trial is testing

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

Who this might be right for
Cutaneous MelanomaMucosal Melanoma
Mural Oncology, Inc 173
Next Page